Search results for "Retinal"

showing 10 items of 631 documents

Epiretinal Membrane Vitrectomy With and Without Intraoperative Intravitreal Dexamethasone Implant: A Systematic Review With Meta-Analysis

2021

Purpose: To evaluate the efficacy of vitrectomy combined with intravitreal dexamethasone implant vs. vitrectomy without the implant in patients with epiretinal membrane (ERM) by conducting a systematic review and meta-analysis.Methods: Studies that compared ERM vitrectomy with and without intraoperative dexamethasone implant with a follow-up ≥3 months were included. The primary outcome was mean best corrected visual acuity (BCVA) change between eyes undergoing ERM vitrectomy combined with dexamethasone implant (DEX group) and eyes undergoing ERM vitrectomy alone (control group) at 3 months. Secondary outcomes included mean BCVA change at 6 months and mean optical coherence tomography centra…

0301 basic medicinemedicine.medical_specialtygenetic structuresmedicine.medical_treatmentvitrectomyVitrectomy03 medical and health sciences0302 clinical medicineOphthalmologymedicinemacular puckerPharmacology (medical)In patientDexamethasone implantMacular thickeningDexamethasonePharmacologybusiness.industrylcsh:RM1-950epiretinal membrane (ERM)medicine.diseaseConfidence intervalmacular pucker surgerylcsh:Therapeutics. Pharmacology030104 developmental biologyDexamethasone implant; epiretinal membrane (ERM); macular pucker; macular pucker surgery; vitrectomyMeta-analysis030221 ophthalmology & optometrySystematic ReviewImplantEpiretinal membranebusinessmedicine.drug
researchProduct

Immunosuppression, peripheral inflammation and invasive infection from endogenous gut microbiota activate retinal microglia in mouse models

2016

Although its actual role in the progression of degenerative processes is not fully known, the persistent activated state of retinal microglia and the concurrent secretion of inflammatory mediators may contribute to neuronal death and permanent vision loss. Our objective was to determine whether non-ocular conditions (immunosuppression and peripheral inflammation) could lead to activation of retinal microglia. Mouse models of immunosuppression induced by cyclophosphamide and/or peripheral inflammation by chemically induced sublethal colitis in C57BL/6J mice were used. Retinal microglia morphology, spatial distribution and complexity, as well as MHCII and CD11b expression levels were determin…

0301 basic medicinemedicine.medical_treatmentImmunologyInflammationMicrobiology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDownregulation and upregulationVirologymedicineColitisMicrogliabiologyImmunosuppressionRetinalmedicine.diseaseTLR2030104 developmental biologymedicine.anatomical_structureIntegrin alpha MchemistryImmunologybiology.proteinmedicine.symptom030217 neurology & neurosurgeryMicrobiology and Immunology
researchProduct

Proteomics Reveals the Potential Protective Mechanism of Hydrogen Sulfide on Retinal Ganglion Cells in an Ischemia/Reperfusion Injury Animal Model

2020

Glaucoma is the leading cause of irreversible blindness and is characterized by progressive retinal ganglion cell (RGC) degeneration. Hydrogen sulfide (H2S) is a potent neurotransmitter and has been proven to protect RGCs against glaucomatous injury in vitro and in vivo. This study is to provide an overall insight of H2S&rsquo

0301 basic medicineneuronal apoptosisgenetic structuresQuantitative proteomicshydrogen sulfidePharmaceutical Sciencelcsh:Medicinelcsh:RS1-441PharmacologyProteomicsRetinal ganglionArticlelabel-free mass spectrometrylcsh:Pharmacy and materia medica03 medical and health scienceschemistry.chemical_compound0302 clinical medicinemitochondrial functionIn vivoDrug DiscoverymedicineRetinaChemistrylcsh:RRetinalmedicine.diseaseequipment and supplieseye diseases030104 developmental biologymedicine.anatomical_structureglaucomaRetinal ganglion cellMolecular Medicinesense organsReperfusion injurysignalling pathways030217 neurology & neurosurgeryPharmaceuticals
researchProduct

The Role of Adrenoceptors in the Retina

2020

The retina is a part of the central nervous system, a thin multilayer with neuronal lamination, responsible for detecting, preprocessing, and sending visual information to the brain. Many retinal diseases are characterized by hemodynamic perturbations and neurodegeneration leading to vision loss and reduced quality of life. Since catecholamines and respective bindings sites have been characterized in the retina, we systematically reviewed the literature with regard to retinal expression, distribution and function of alpha1 (α1)-, alpha2 (α2)-, and beta (β)-adrenoceptors (ARs). Moreover, we discuss the role of the individual adrenoceptors as targets for the treatment of retinal diseases.

0301 basic medicineretinaAdrenergic receptorgenetic structuresCentral nervous systemReviewα<sub>1</sub>-ARBiology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRetinal DiseasesmedicinedistributionAnimalsHumansα1-ARlcsh:QH301-705.5NeuronsRetinafunctionBinding Sitesα<sub>2</sub>-ARNeurodegenerationRetinalNeurodegenerative DiseasesGeneral Medicinemedicine.diseaseeye diseasesReceptors Adrenergic030104 developmental biologymedicine.anatomical_structurechemistrylcsh:Biology (General)β-ARNeuroscience030217 neurology & neurosurgeryα2-ARCells
researchProduct

Ocular Clocks: Adapting Mechanisms for Eye Functions and Health

2018

Vision is a highly rhythmic function adapted to the extensive changes in light intensity occurring over the 24-hour day. This adaptation relies on rhythms in cellular and molecular processes, which are orchestrated by a network of circadian clocks located within the retina and in the eye, synchronized to the day/night cycle and which, together, fine-tune detection and processing of light information over the 24-hour period and ensure retinal homeostasis. Systematic or high throughput studies revealed a series of genes rhythmically expressed in the retina, pointing at specific functions or pathways under circadian control. Conversely, knockout studies demonstrated that the circadian clock re…

0301 basic medicineretinavisiongenetic structuresPeriod (gene)[SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/NeurobiologyCircadian clockCLOCK ProteinsGene ExpressionContext (language use)melatoninReviewBiologyrhythm03 medical and health scienceschemistry.chemical_compoundCircadian ClocksmedicineAnimalsHumansCircadian rhythmOcular Physiological PhenomenaComputingMilieux_MISCELLANEOUSRetinaAdaptation OcularRetinalphotoreceptorCircadian RhythmCLOCKLight intensity030104 developmental biologymedicine.anatomical_structurecircadianchemistrysense organsdopamineNeuroscienceInvestigative Ophthalmology & Visual Science
researchProduct

Oxidation-Induced Increase In Photoreactivity of Bovine Retinal Lipid Extract

2017

Open access original paper Source : 10th EPR Workshop on Applications of EPR in Biology and Medicine, 2016 in Krakow, POLAND.; International audience; The mammalian retina contains a high level of polyunsaturated fatty acids, including docosahexaenoic acid (22:6) (DHA), which are highly susceptible to oxidation. It has been shown that one of the products of DHA oxidation-carboxyethylpyrrole (CEP), generated in situ, causes modifications of retinal proteins and induces inflammation response in the outer retina. These contributing factors may play a role in the development of age-related macular degeneration (AMD). It is also possible that some of the lipid oxidation products are photoreactiv…

0301 basic medicineretinaépithéliumLightOrganes des sensalpha-TocopherolBiochemistrysinglet oxygenchemistry.chemical_compoundspectrométrie de masseChromatography High Pressure Liquidrod outer segmentschemistry.chemical_classificationLiposomePhotorSuperoxideSinglet oxygenvitamine ephotorGeneral MedicineLipidsvertebrate retinaBiochemistryDocosahexaenoic acidAlimentation et Nutritionoxidized phospholipidsfatty-acid compositionRetina;Lipids;Polyunsaturated fatty acids;Oxidation;Photor;ROD OUTER SEGMENTS;GLYCATION END-PRODUCTS;SINGLET OXYGEN;PIGMENT EPITHELIUM;VITAMIN-E;MACULAR DEGENERATION;OXIDIZED PHOSPHOLIPIDS;MASS-SPECTROMETRY;VERTEBRATE RETINAOxidation-Reductionpolyunsaturated fatty acidsphospholipideSpectrometry Mass Electrospray IonizationChromatography Gasmacular degenerationoxidationrétineElectrospray ionizationvitamin-eSensory OrgansBiophysicsMédecine humaine et pathologieRetinalipids03 medical and health sciencesLipid oxidationZeaxanthinsacide gras polyinsaturé[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyOxidationAnimalsFood and NutritionlipideOriginal PaperReactive oxygen speciesChromatography030102 biochemistry & molecular biologyElectron Spin Resonance SpectroscopyoxydationRetinaldégénérescence maculaireCell Biologymass-spectrometryvertébrépigment epitheliumOxygen030104 developmental biologychemistryLiposomesglycation end-productsQuantum TheoryCattleSpin LabelsHuman health and pathologyPolyunsaturated fatty acidssense organs[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

2015

Purpose: The aim of this study was to investigate the interaction and co-localization of novel interacting proteins with the Leber congenital amaurosis (LCA) associated protein aryl hydrocarbon receptor interacting protein-like 1 (AIPL1). Methods: The CytoTrapXR yeast two-hybrid system was used to screen a bovine retinal cDNA library. A novel interaction between AIPL1 and members of the family of EB proteins was confirmed by directed yeast two-hybrid analysis and co-immunoprecipitation assays. The localization of AIPL1 and the EB proteins in cultured cells and in retinal cryosections was examined by immunofluorescence microscopy and cryo-immunogold electron microscopy. Results: Yeast two-hy…

0303 health sciencesRetinaMultidisciplinaryMicrotubule-associated proteinCiliumRetinalmacromolecular substancesBiologyProtein–protein interactionCell biology03 medical and health scienceschemistry.chemical_compound0302 clinical medicinemedicine.anatomical_structurechemistryMicrotubuleCiliogenesismedicineEye Proteins030217 neurology & neurosurgery030304 developmental biologyPLOS ONE
researchProduct

An optimal population code for global motion estimation in local direction-selective cells

2021

AbstractNervous systems allocate computational resources to match stimulus statistics. However, the physical information that needs to be processed depends on the animal’s own behavior. For example, visual motion patterns induced by self-motion provide essential information for navigation. How behavioral constraints affect neural processing is not known. Here we show that, at the population level, local direction-selective T4/T5 neurons in Drosophila represent optic flow fields generated by self-motion, reminiscent to a population code in retinal ganglion cells in vertebrates. Whereas in vertebrates four different cell types encode different optic flow fields, the four uniformly tuned T4/T5…

0303 health scienceseducation.field_of_studyMatching (graph theory)Computer sciencebusiness.industryPopulationPattern recognitionENCODERetinal ganglion03 medical and health sciences0302 clinical medicineFlow (mathematics)Physical informationMotion estimationArtificial intelligenceeducationbusiness030217 neurology & neurosurgery030304 developmental biologyCoding (social sciences)
researchProduct

The implication of omega-3 polyunsaturated fatty acids in retinal physiology

2007

International audience; Neuronal tissues such as the retina and the brain are characterized by their high content in phospholipids. In the retina, phospholipids can account for until 80% of total lipids and are mainly composed by species belonging to phosphatidyl-choline and phosphatidyl-ethanolamine sub-classes. Within fatty acids esterified on retinal phospholipids, omega-3 PUFAs are major components since docosahexaenoic acid (DHA) can represent until 50% of total fatty acids in the photoreceptor outer segments.For long time, DHA is known to play a major role in membrane function and subsequently in visual processes by affecting permeability, fluidity, thickness and the activation of mem…

030309 nutrition & dieteticsPhospholipidlcsh:TP670-699Biologymedicine.disease_causeBiochemistry03 medical and health scienceschemistry.chemical_compoundINFLAMMATION[SDV.IDA]Life Sciences [q-bio]/Food engineeringmedicineOMEGA-3 POLYINSATURED FATTY ACIDSOXIDATIVE STRESSRETINAUnsaturated fatty acid030304 developmental biologychemistry.chemical_classification0303 health sciencesRetinaOmega-3 polyunsaturated fatty acidsfood and beveragesRetinalMacular degenerationmedicine.diseasemedicine.anatomical_structurechemistryBiochemistryDocosahexaenoic acidVASCULOGENESISlipids (amino acids peptides and proteins)lcsh:Oils fats and waxesOxidative stressFood SciencePolyunsaturated fatty acid
researchProduct

Widening use of dexamethasone implant for the treatment of macular edema

2017

Vincenza Bonfiglio, Michele Reibaldi, Matteo Fallico, Andrea Russo, Alessandra Pizzo, Stefano Fichera, Carlo Rapisarda, Iacopo Macchi, Teresio Avitabile, Antonio Longo Department of Ophthalmology, University of Catania, Catania, Italy Abstract: Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis. The implant is formulated in a biodegradable copolymer to release the active ingredient within the vitreous chamber for up to 6 months after an intravitreal injection, allowing a prolonged interval of effica…

3003intravitrealgenetic structuresimplantmedicine.medical_treatmentPharmaceutical ScienceVitrectomyReviewDrug Implantcorticosteroids0302 clinical medicineGlucocorticoidCentral retinal vein occlusionDrug DiscoveryDelayed-Action PreparationCorticosteroidRandomized Controlled Trials as TopicDrug ImplantsCorticosteroids; Dexamethasone; Implant; Intravitreal; Macular edema; Pharmacology; 3003; Drug Discovery3003 Pharmaceutical ScienceDiabetic retinopathyIntravitreal InjectionsUveitismedicine.drugHumanmedicine.medical_specialtydexamethasone03 medical and health sciencesOphthalmologymedicineHumansMacular edemaGlucocorticoidsDexamethasonePharmacologyMacular edemaDiabetic Retinopathybusiness.industryIntravitreal InjectionDrug Discovery3003 Pharmaceutical Sciencelcsh:RM1-950Macular degenerationmedicine.diseaseeye diseasesSurgerylcsh:Therapeutics. PharmacologyDelayed-Action Preparations030221 ophthalmology & optometryBranch retinal vein occlusionsense organsbusiness030217 neurology & neurosurgeryDrug Design, Development and Therapy
researchProduct